Atrás
Rango del Día
$146.61
$153.48
Rango de 52 Semanas
$49.00
$200.00
Volumen
172,006
Promedio 50D / 200D
$170.97
/
$110.33
Cierre Anterior
$151.14
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -76.5 | 0.3 |
| P/B | 40.7 | 2.9 |
| ROE % | -65.7 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$203.00
+34.6%
Low: $187.00
High: $223.00
EPS Futuro
-$2.14
Ingresos Est.
26 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$22.07
$14.56 – $42.72
|
1.4 B | 2 |
| FY2029 |
$16.14
$10.65 – $31.23
|
990 M | 2 |
| FY2028 |
$8.66
$2.62 – $21.95
|
560 M | 4 |
Puntos Clave
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -29.39M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-65.70%
ROIC-43.15%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.00
Current Ratio24.31
Interest Coverage0.00
Valoración
P/E Ratio
-76.45
P/B Ratio40.69
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -77.61M |
| ROE | -65.70% | ROA | -51.02% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -29.39M |
| ROIC | -43.15% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 24.31 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -76.45 | P/B Ratio | 40.69 |
| P/S Ratio | N/A | PEG Ratio | -0.72 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 5.93B | Enterprise Value | 5.90B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -77.61M | -36.14M | -31.63M | -12.65M | -9.67M |
| EPS (Diluted) | -2.31 | -1.18 | -1.19 | -0.63 | -0.40 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -84.21M | -40.00M | -31.67M | -12.82M | -9.80M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 152.13M | 94.64M | 44.27M | 18.35M | 25.74M |
| Total Liabilities | 6.31M | 4.21M | 2.77M | 33.44M | 32.78M |
| Shareholders' Equity | 145.82M | 90.43M | 41.50M | -15.09M | -7.04M |
| Total Debt | 537,000.0 | 886,000.0 | 866,000.0 | 31.81M | 31.81M |
| Cash & Equivalents | 31.68M | 88.16M | 42.09M | 17.34M | 25.62M |
| Current Assets | 147.07M | 89.94M | 42.81M | 17.43M | 25.67M |
| Current Liabilities | 6.05M | 3.63M | 2.10M | 1.64M | 972,000.0 |